via AI.Nony.Mous
Finding could revolutionise how all vaccines could be made to be longer lasting
The SARS-Cov-2 pandemic illustrates how variable vaccines can be in their length of efficacy, with regular boosters needed to keep people protected. In comparison, the immunity generated by a single vaccination against the measles virus can last decades.
It has always remained a scientific mystery as to why only some vaccines lead to life-long protection. Now a paper published in the journal, Immunity, led by Prof. David Tarlinton and Dr Marcus Robinson, both from Monash University’s Central Clinical School in Melbourne, Australia, has found that the clue likely lies in the body producing a unique subtype of an immune cell in response to some but not other vaccinations. The finding could revolutionise how all vaccines could be made to be longer lasting.
Vaccines trick our immune cells into thinking the body has been infected. In response, we produce antibodies to fight off what is perceived as an infection. According to Dr Robinson, “most vaccines work by generating high levels of antibodies against these invaders, but how long these antibodies persist in the body is highly variable by vaccine,” he said. “Now we know that the clue is in whether vaccines generate a special subtype of immune cell that produces antibody for long times to fight off infection indefinitely.”
Using an animal model, the researchers studied the lifespan of antibody-secreting cells, identifying surface markers on these cells that indicated longevity. The scientists used a method called ‘timestamping’, which effectively tracks individual antibody-secreting cells across their entire lifespan. “We found those cells with particular markers on them were more likely to be long lasting. They also expressed really distinct patterns of genes, so we think longevity is programmed into the cell.” Dr Robinson said.
“It is these cells we need to target when developing vaccines we want to provide long-lasting protection.”
Importantly the researchers also found that there is a maximum number of these long-lasting antibody-secreting cells the body can hold at any one time, and they generally reside in special sites in tissues like the bone marrow – so improved vaccines will need to focus on maintaining these reservoirs of long acting cells, according to Dr Robinson.
Original Article: Making vaccines longer lasting
More from: Monash University
The Latest Updates from Bing News
Go deeper with Bing News on:
Long lasting vaccines
- Vaccine expert 'very worried' by whooping cough deaths
A leading vaccine expert says he is "very worried" by the large increase in whooping cough cases which have led to the deaths of five babies in England this year.Professor Sir Andrew Pollard, head of ...
- Moderna says FDA delayed RSV vaccine approval to end of May
The FDA has not informed Moderna of any issues related to the vaccine's safety, efficacy or quality that would prevent its approval, the biotech company said.
- M’sia ceased distributing AstraZeneca vaccine ‘long ago’, says doctor
The distribution of the AstraZeneca vaccine for Covid-19 in Malaysia ceased long ago, after the pandemic was brought under control.
- A new cholera vaccine will increase supply, but will it be enough to manage global outbreaks?
Along with a new manufacturing plant that will be at full capacity next year, EuBiologics will be able to produce 50 million cholera vaccine doses in 2024, and 80 million in 2025, said Lynch — most of ...
- An adjuvant made in yeast could lower vaccine cost and boost availability
Adjuvants make vaccines more effective, though one of the best is an expensive extract from the soap bark tree. To lower the cost and avoid the laborious extraction process from bark, synthetic ...
Go deeper with Bing News on:
Life-long protection vaccines
- Whooping cough: Vaccine expert 'very worried' by whooping cough deaths
Uptake of the maternal pertussis vaccine, which is offered during every pregnancy and provides some protection to babies in the first few months of life, has also dropped ... up call to the NHS", ...
- COVID-19 vaccines: Get the facts
In some people, COVID-19 vaccines can lead to heart complications called myocarditis and pericarditis. Myocarditis is the swelling, also called inflammation, of the heart muscle. Pericarditis is the ...
- Vaccine expert 'very worried' by whooping cough deaths
A leading vaccine expert says he is "very worried" by the large increase in whooping cough cases which have led to the deaths of five babies in England this year.Professor Sir Andrew Pollard, head of ...
- Sanofi strikes licensing pact with Novavax for COVID, flu-COVID combo shots
“We’re excited by the prospect of combining Novavax’s adjuvanted COVID-19 vaccine that has shown high efficacy and favorable tolerability, with our rich portfolio of differentiated flu vaccines that ...
- Everything you need to know about the three vaccines your child will be offered in First Year
We've put together this handy guide with a breakdown of what these vaccines are, their importance and when you can expect your child to have their vaccinations.